Anne Lingford-Hughes

Anne Lingford-Hughes's AcademicInfluence.com Rankings

Biology

#14639

World Rank

#18443

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Anne Lingford-Hughes Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anne Lingford-Hughes is a British psychiatrist who is Professor of Addiction Biology at Imperial College London. She works on addictions at the Central and North West London NHS Foundation Trust. Her research uses neuroimaging and pharmacology to understand the neurobiology of addiction.

(See a Problem?)

Anne Lingford-Hughes's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review (2007) (2091)
The dopamine theory of addiction: 40 years of highs and lows (2015) (496)
Effects of cannabis use on outcomes of psychotic disorders: systematic review (2008) (267)
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study (2021) (201)
Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity (2012) (183)
Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology (2004) (171)
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment (2016) (170)
Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. (2001) (155)
Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy (1998) (150)
Chronic ethanol and pentobarbital administration in the rat: effects on GABAA receptor function and expression in brain. (1990) (150)
The effects of elevated endogenous GABA levels on movement-related network oscillations (2013) (145)
Is socioeconomic status in early life associated with drug use? A systematic review of the evidence. (2009) (136)
A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study (2018) (135)
British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017 (2017) (134)
Neural substrates of cue reactivity and craving in gambling disorder (2016) (130)
Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration (2017) (118)
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology (2019) (116)
Blockade of alcohol's amnestic activity in humans by an α5 subtype benzodiazepine receptor inverse agonist (2007) (114)
Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence? (2005) (111)
Imaging the GABA-Benzodiazepine Receptor Subtype Containing the α5-Subunit In Vivo with [11C]Ro15 4513 Positron Emission Tomography (2002) (106)
GABAB receptors in addiction and its treatment. (2010) (97)
Neurobiology of addiction and implications for treatment (2003) (97)
Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers (2015) (96)
Endogenous Opioid Release in the Human Brain Reward System Induced by Acute Amphetamine Administration (2012) (94)
Socio-economic status in childhood and later alcohol use: a systematic review. (2007) (94)
The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study (2007) (94)
The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: A pilot [11C]Ro15-4513 positron emission tomography study (2013) (94)
Opioids and anxiety (2011) (93)
Functional connectivity analysis of the neural circuits of opiate craving: “more” rather than “different”? (2003) (78)
Amphetamine induced endogenous opioid release in the human brain detected with [¹¹C]carfentanil PET: replication in an independent cohort. (2014) (76)
Does alcohol increase the risk of overdose death: the need for a translational approach. (2008) (75)
Brain dopamine response in human opioid addiction (2008) (73)
Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. (2018) (73)
The clinical pharmacology of acamprosate (2014) (71)
Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge (2010) (70)
Ethanol Reversal of Tolerance to the Respiratory Depressant Effects of Morphine (2015) (64)
Alcohol and Alzheimer's Disease—Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease? (2016) (63)
Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers (2008) (62)
Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]diprenorphine PET study (2009) (62)
Using [11C]Diprenorphine to Image Opioid Receptor Occupancy by Methadone in Opioid Addiction: Clinical and Preclinical Studies (2005) (59)
Removal of extracerebral tissues in dual-echo magnetic resonance images via linear scale-space features. (1999) (58)
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (2012) (57)
Cerebral blood flow predicts differential neurotransmitter activity (2017) (57)
Decreased hippocampal translocator protein (18 kDa) expression in alcohol dependence: a [11C]PBR28 PET study (2017) (56)
In Vivo Imaging of Cerebral Dopamine D3 Receptors in Alcoholism (2014) (52)
Association between the serotonin transporter gene and alcohol consumption in social drinkers (2005) (51)
GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study (2005) (50)
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective (2019) (49)
11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis (2017) (49)
A [11C]Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced α5 benzodiazepine receptors in limbic regions (2012) (48)
Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography study. (2007) (48)
Comparison of cannabinoids in hair with self‐reported cannabis consumption in heavy, light and non‐cannabis users (2016) (46)
Addiction: the clinical interface (2008) (46)
Elevating Endogenous GABA Levels with GAT-1 Blockade Modulates Evoked but Not Induced Responses in Human Visual Cortex (2013) (44)
Addiction Imaging in clinical neuroscience (2003) (43)
Acute increases in synaptic GABA detectable in the living human brain: A [11C]Ro15-4513 PET study (2014) (42)
Comparison of ethyl glucuronide in hair with self-reported alcohol consumption. (2012) (41)
Substance abuse disorders. (2012) (41)
Neuropharmacology of addiction and how it informs treatment. (2010) (39)
Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial (2016) (39)
Levels of gamma-aminobutyric acid-benzodiazepine receptors in abstinent, alcohol-dependent women: preliminary findings from an 123I-iomazenil single photon emission tomography study. (2000) (39)
Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation (2018) (38)
GABA-A receptor differences in schizophrenia: a positron emission tomography study using [11C]Ro154513 (2020) (38)
Human brain imaging and substance abuse. (2005) (36)
Differences between magnetoencephalographic (MEG) spectral profiles of drugs acting on GABA at synaptic and extrasynaptic sites: A study in healthy volunteers (2015) (36)
d-Cycloserine and performance under different states of anxiety in healthy volunteers (2007) (35)
Initial evaluation of123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects (1997) (35)
Significant reductions in human visual gamma frequency by the gaba reuptake inhibitor tiagabine revealed by robust peak frequency estimation (2016) (35)
What makes alcohol-dependent individuals early in abstinence crave for alcohol: exposure to the drink, images of drinking, or remembrance of drinks past? (1998) (34)
GABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse models (2018) (34)
Nature or Nurture? Determining the Heritability of Human Striatal Dopamine Function: an [18F]-DOPA PET Study (2013) (34)
Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [11C]Ro15-4513 PET images (2012) (33)
Investigating expectation and reward in human opioid addiction with [11C]raclopride PET (2013) (32)
A pilot study of the effectiveness of d-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects (2011) (31)
A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist (2005) (30)
Reduced thalamic grey matter volume in opioid dependence is influenced by degree of alcohol use: a voxel-based morphometry study (2008) (30)
Alcohol-related brain damage: report from a Medical Council on Alcohol Symposium, June 2010. (2012) (30)
The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description (2015) (30)
Alcohol Hangover: Underlying Biochemical, Inflammatory and Neurochemical Mechanisms. (2019) (30)
Naltrexone ameliorates functional network abnormalities in alcohol‐dependent individuals (2017) (29)
Measurement of GABA using J‐difference edited 1H‐MRS following modulation of synaptic GABA concentration with tiagabine (2014) (29)
Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approach (2016) (28)
Alcohol -Use Disorders: The NICE guideline on diagnosis, assessment and management of harmful drinking and alcohol dependence (2011) (27)
The clinical and cost-effectiveness of brief advice for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (2014) (26)
Low Sensitivity of the Positron Emission Tomography Ligand [11C]Diprenorphine to Agonist Opiates (2007) (26)
History of cigarette smoking is associated with higher limbic GABAA receptor availability (2013) (26)
Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study (2017) (26)
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence (2017) (26)
Acute naltrexone does not remediate fronto‐striatal disturbances in alcoholic and alcoholic polysubstance‐dependent populations during a monetary incentive delay task (2017) (25)
Attentional bias for alcohol-related information in adolescents with alcohol-dependent parents. (2006) (25)
Evidence for GABA‐A receptor dysregulation in gambling disorder: correlation with impulsivity (2016) (25)
Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder. (2022) (24)
CLINICAL AND IMAGING STUDY: Imaging alcohol cue exposure in alcohol dependence using a PET 15O‐H2O paradigm: results from a pilot study (2006) (24)
Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge (2019) (24)
Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis (2020) (24)
Cannabis use and risk of psychotic or aff ective mental health outcomes: a systematic review (2007) (24)
A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol‐dependent patients (2003) (22)
Drugs for Relapse Prevention of Alcoholism (2005) (21)
Treating anxiety complicated by substance misuse (2002) (21)
Erratum: Initial evaluation of 123 I-5-I-R91150, a selective 5-HT(2A) ligand for single-photon emission tomography, in healthy human subjects (European Journal of Nuclear Medicine (1997) 24 (119-124)) (1997) (20)
Are prescribed benzodiazepines likely to affect the availability of the 18 kDa translocator protein (TSPO) in PET studies? (2013) (19)
Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects. (1997) (19)
Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery (2017) (18)
Validated Method for the Quantification of Baclofen in Human Plasma Using Solid-Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry. (2016) (17)
Opioid Imaging. (2007) (17)
Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals (2018) (16)
Interdisciplinary working in public health research: a proposed good practice checklist (2018) (15)
Using Baclofen to Explore GABA-B Receptor Function in Alcohol Dependence: Insights From Pharmacokinetic and Pharmacodynamic Measures (2018) (15)
Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments? (2012) (14)
The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description (2016) (14)
Prevention of suicide and reduction of self-harm among people with substance use disorder: A systematic review and meta-analysis of randomised controlled trials. (2019) (14)
The clinical effectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR). (2014) (14)
γ-aminobutyric acid as a metabolite: Interpreting magnetic resonance spectroscopy experiments (2016) (14)
Biomarkers for detecting thiamine deficiency--improving confidence and taking a comprehensive history are also important. (2009) (13)
Reframing the science and policy of nicotine, illegal drugs and alcohol – conclusions of the ALICE RAP Project (2017) (13)
Acute D 3 Antagonist GSK 598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence (2017) (12)
Neurobiology and principles of addiction and tolerance (2012) (12)
Resting state synchrony in anxiety-related circuits of abstinent alcohol-dependent patients (2013) (12)
Future directions in substance dependence research. (2003) (11)
Alcohol and the Brain (2021) (11)
Prehabilitation in Alcohol Dependence as a Treatment Model for Sustainable Outcomes. A Narrative Review of Literature on the Risks Associated With Detoxification, From Animal Models to Human Translational Research (2019) (11)
Antidepressant treatment response: 'I want it all, and I want it now!'†. (2016) (10)
Pharmacological treatment of addiction (2007) (10)
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence (2017) (10)
Infecting the brain to stop addiction? (2004) (10)
Neuropharmacology of addiction (2006) (9)
What Determines Harm from Addictive Substances and Behaviours (2016) (9)
Using [11C]Ro15 4513 PET to characterise GABA-benzodiazepine receptors in opiate addiction: Similarities and differences with alcoholism (2016) (9)
Human Functional Neuroimaging Connectivity Research in Dependence (2005) (9)
Neural and neurocognitive markers of vulnerability to gambling disorder: a study of unaffected siblings (2019) (9)
Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol‐dependent and polysubstance‐dependent individuals (2018) (8)
Influence of agonist induced internalization on [3H]Ro15‐4513 binding—an application to imaging fluctuations in endogenous GABA with positron emission tomography (2015) (8)
Assessment of GABAA benzodiazepine receptor (GBzR) sensitivity in patients with alcohol dependence. (2008) (8)
In vivo imaging of GABAA receptors using sequential whole-volume iodine-123 iomazenil single-photon emission tomography (2005) (7)
Cannabis use and risk of psychotic or affective mental health outcomes : a systematic review. Commentary (2007) (7)
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2) (2019) (7)
Hazardous drinking and alcohol use disorders. (2022) (6)
Gender equality in academic publishing: action from the BJPsych (2020) (6)
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease (2022) (6)
The neurobiology of substance use and addiction: evidence from neuroimaging and relevance to treatment (2020) (6)
Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence (2017) (5)
Erratum: Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease? (2016) (5)
Impact of COVID-19 on mental health research: is this the breaking point? (2022) (5)
Does human presynaptic striatal dopamine function predict social conformity? (2014) (5)
Addressing unmet needs in opiate dependence: supporting detoxification and advances in relapse prevention (2021) (5)
Opioid imaging. (2006) (4)
Addiction and substance misuse (2004) (4)
Brief intervention for alcohol misuse in people attending sexual health clinics: study protocol for a randomized controlled trial (2012) (4)
2 – Clinical neuroanatomy (2012) (4)
Opioid use disorder and the brain: a clinical perspective. (2021) (4)
Chapter 9 – Neuroimaging (2007) (4)
65. Reduced levels of the GABA benzodiazepine receptor in alcohol dependency: A 123I-iomazenil SPET study (1997) (4)
Discussion and integration of key findings (2016) (4)
Fundamentals of Clinical Psychopharmacology (3rd ed) (2006) (4)
Implications for research, policy, and practice (2016) (4)
Αlpha 5 subunit-containing GABAA receptors in temporal lobe epilepsy with normal MRI (2021) (3)
Acute acetate administration increases endogenous opioid levels in the human brain: A [11C]carfentanil molecular imaging study (2021) (3)
Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease? (2017) (3)
Substitution treatment in addiction: there is more than one way... (2016) (3)
Brain Imaging in Addiction (2012) (3)
Psychiatry and the global drugs debate: what every psychiatrist needs to know (2020) (3)
Widespread cell stress and mitochondrial dysfunction in early Alzheimers Disease (2021) (3)
Determinants of risky substance use and risky gambling (2016) (2)
Chronic alcohol exposure differentially modulates structural and functional properties of amygdala: A cross‐sectional study (2020) (2)
P.l.c.044 Paradoxical effects of GABA on the in vivo uptake of the partial inverse GABA agonist [3H]Ro15-4513 in rat brain (2009) (2)
A feasibility study of an intervention for structured preparation before detoxification in alcohol dependence: the SPADe trial protocol (2019) (2)
Unleashing talent in mental health sciences: gender equality at the top. (2018) (2)
COVID-19 and substance use disorders: a review of international guidelines for frontline healthcare workers of addiction services (2022) (2)
The Application of Nof-1 Treatment Trials in Schizophrenia : A Systematic Review (2018) (2)
Determinants of harmful substance use and harmful gambling (2016) (2)
P.6.c.008 Can personality traits elucidate the relationship between substance dependence and opioid receptor availability? (2008) (2)
A dose-finding design for dual-agent trials with patient-specific doses for one agent with application to an opiate detoxification trial (2021) (2)
Results of sensitivity analyses (2014) (2)
Chronic alcohol exposure differentially modulates structural and functional properties of amygdala: A cross‐sectional study (2020) (2)
P.3.013 Interaction between alcohol and opioids in opioid-dependent subjects (2010) (1)
Decreased GABA-A Receptor Binding in Association With β-Lactam Antibiotic Use. (2019) (1)
Gender differences in the pattern of reduced levels of the GABA benzodiazepine receptor in alcohol dependency - An L23 I-iomazenil SPECT and MRI study. (1998) (1)
Therapeutic Armamentarium in Substance‐Related Disorders (2003) (1)
Key concepts in psychopharmacology (2004) (1)
Impact of COVID-19 restrictions on alcohol consumption behaviours (2021) (1)
Measurement of brain GABA-benzodiazepine receptor levels in vivo using emission tomography. (1999) (1)
Decreased GABA-A Receptor Binding in Association With β-Lactam Antibiotic Use. (2019) (1)
Drugs of abuse (2019) (1)
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study (2023) (1)
Chapter 66 – Opioids Neuroimaging (2013) (1)
Initial evaluation of123|-5-|-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects (2006) (1)
Determinants of transitions from harmful to low-risk substance use and gambling (2016) (1)
Reflections and best practice recommendations for interdisciplinary working: a case study on the identification of the determinants of addiction from the Addiction and Lifestyles In Contemporary Europe Reframing Addictions Project (ALICE RAP) (2014) (1)
UNDERSTANDING CAUSAL PATHWAYS: A RESPONSE TO THE COMMENTARIES (2008) (1)
Brain circuits involved in craving (2000) (1)
P.1.i.042 A multicenter positron emission tomography study of GABA receptor availability in adults with autism (2017) (1)
Comprar Edwards' Treatment Of Drinking Problems. A Guide For The Helping Professions 6th Ed. | Keith Humphreys | 9781107519527 | Cambridge University Press (2016) (1)
C-11-diprenorphine PET imaging of opioid binding during chronic methadone treatment and early abstinence (2000) (1)
P.6.f.002 Endogenous opioid release in pathological gamblers after an oral amphetamine challenge: a [11C]carfentanil PET study (2014) (1)
THE EFFECT OF MINOCYCLINE ON NEUROINFLAMMATION AFTER BRAIN TRAUMA (2016) (1)
The ICCAM platform study (2017) (1)
QUANTIFYING MITOCHONDRIAL AND SYNAPTIC FUNCTION IN ALZHEIMER’S DISEASE USING [18F]BCPP-EF, [11C]SA4503 AND [11C]UCB-J PET IMAGING (2019) (1)
Functional evaluation of NK1 antagonism on cue reactivity in opiate dependence; An fMRI study (2021) (1)
Does opioid induced dopamine release in humans require a subjective "high"? A pet study with 11C-raclopride (2002) (1)
PHARMACOLOGY AND CELL METABOLISM Assessment of GABAA Benzodiazepine Receptor (GBzR) Sensitivity in Patients with Alcohol Dependence (2008) (1)
There is more to dopamine than just pleasure. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'. (2002) (1)
Drug use and associated neuropsychiatric conditions (2020) (1)
Neuroscience Perspectives on Addiction: Overview (2015) (0)
Bridging the preclinical - clinical gap (2005) (0)
S14IDENTIFICATION OF NEUROINFLAMMATION IN THE BRAIN IN VIVO AND IN VITRO AND THERAPEUTIC STRATEGIES TO COMBAT ITS PROGRESSIONS14.1INFLAMMATORY PROCESSES IN NEURODEGENERATIVE DISEASESS14.2IMAGING NEUROINFLAMMATION IN ALCOHOLISMS14.3CAN PERIPHERAL MARKERS INDICATE NEUROINFLAMMATION?S14.4INFLAMMASOME I (2011) (0)
Noradrenergic function in generalised anxiety disorder (GAD): A single photon emission tomography (SPET) study (2008) (0)
Comorbidity of substance use and psychiatric disorders (2020) (0)
P.4.024 Using positron emission tomography to investigate microglial activation in alcohol dependence: preliminary findings (2013) (0)
A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod (2023) (0)
P.3.014 An investigation of the role of the brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder (ASD) using the PET ligand [11C]Ro15-4513 (2012) (0)
Pharmacotherapeutic interventions in alcohol and illicit drug dependence (2007) (0)
P.6.c.007 Association between opioid receptor availability and anxiety in healthy controls but not in substance dependence (2009) (0)
P2-365 ADDED DIAGNOSTIC VALUE OF 18F- FLUTEMETAMOL PET SCANNING IN YOUNG PATIENTS WITH DEMENTIA QUANTIFYING MITOCHONDRIAL AND SYNAPTIC FUNCTION IN ALZHEIMER’S DISEASE USING 18 F]BCPP-EF, [ 11 AND [ 11 C]UCB-J PET IMAGING (2019) (0)
Altered brain opioid receptor density after withdrawal from methadone treatment (2002) (0)
P38. The Relationship Between Reward and Impulsivity in Substance Dependence: An fMRI Study (2022) (0)
Alterations in white matter microstructure in alcohol and alcohol‐polydrug dependence: Associations with lifetime alcohol and nicotine exposure (2022) (0)
Service Users’ Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists? (2022) (0)
PL4IMAGING THE NEUROPHARMACOLOGY OF ALCOHOLISM (2015) (0)
Proforma for clinicians delivering brief advice (2014) (0)
A human pet study of dopamine response to hydromorphone (2002) (0)
Alterations in white matter microstructure in alcohol and alcohol‐polydrug dependence: Associations with lifetime alcohol and nicotine exposure (2022) (0)
Faculty of 1000 evaluation for Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. (2012) (0)
GABA(A) Receptors in Autism - a Multicenter Positron Emission Tomography Study (2015) (0)
Pursuing treatment outcomes other than abstinence (2016) (0)
S.15.03 Imaging GABA-benzodiazepine receptor subtypes in addiction (2012) (0)
Hazardous drinking and alcohol use disorders. (2022) (0)
C.10.01 Experimental human evidence for a role of the opioid system in alcohol dependence (2014) (0)
Characterisation of the Effects of Alcohol use and Abuse on the Brain (1996) (0)
Cerebral blood flow predicts differential neurotransmitter activity (2018) (0)
Religion, spirituality, and values in treatment (2016) (0)
Highlights for this issue (2019) (0)
Faculty Opinions recommendation of Gabapentin combined with naltrexone for the treatment of alcohol dependence. (2011) (0)
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls (2023) (0)
S.07.07 Increased opioid receptor binding in early abstinence from dependent opioid and alcohol use and relationship to craving (2007) (0)
Do Gut Hormones attenuate eating and addictive behaviours in obesity, alcohol and nicotine dependence? (2018) (0)
Faculty Opinions recommendation of Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. (2007) (0)
P.6.b.006 Alcohol dependent patients have blunted endogenous opioid release measured using [11C]carfentanil PET and dexamphetamine challenge (2016) (0)
Alcohol misuse and anxiety : prevalence and incidence (2002) (0)
Brain dopamine response in human opioid addiction R. C. Daglish, Tim M. Williams, Sue J. Wilson, Lindsay G. Taylor, Chin B. Eap, (2008) (0)
Brain imaging alcohol cue-reactivity (2004) (0)
alcohol treatments? Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and (2012) (0)
S10-1NEURO-INFLAMMATION AND ALCOHOL ADDICTION: CORRELATION WITH MEMORY AND MOTOR IMPAIRMENT (2017) (0)
Management of medically assisted withdrawal from alcohol in acute adult mental health and specialist addictions in-patient services: UK clinical audit findings (2023) (0)
Imaging the role of dopamine in human opioid addicts (2010) (0)
Imaging synaptic microstructure and synaptic loss in vivo in early Alzheimers Disease (2021) (0)
Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approach (2016) (0)
S.18.04 Does heroin release dopamine? A positron emission tomography study (2005) (0)
Challenges the addiction field must overcome to avert being the Cinderella of medicine. (2017) (0)
Boosting the diagnostic power of amyloid-β PET using a data-driven spatially informed classifier for decision support (2021) (0)
Faculty of 1000 evaluation for A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. (2012) (0)
S.07.08 Using Positron Emission Tomography to investigate microglial activation in alcohol dependence: preliminary findings (2013) (0)
S24-2THE ICCAM PLATFORM: TO INVESTIGATE THE NEUROPHARMACOLOGY OF BRAIN PROCESSES RELEVANT TO ADDICTION (2017) (0)
availability receptor 3 / D 2 History of cannabis use is not associated with alterations in striatal dopamine D (2011) (0)
A feasibility trial of an intervention in alcohol dependence for structured preparation before detoxification versus usual care: the SPADe trial results (2021) (0)
Noradrenergic dysfunction in generalised anxiety disorder (GAD: a SPET study using a clonidine challenge (2002) (0)
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study (2023) (0)
C.07.01 Neurobiology of alcohol dependence (2013) (0)
IMAGING GABAA RECEPTOR SUBTYPES WITH PET. (2004) (0)
Assessment of patients with drinking problems (2016) (0)
GABA A benzodiazepine receptor sensitivity in patients with alcohol dependence (2008) (0)
The effects of zolpidem on in vivo binding of [C11]-flumazenil and [C11]-Ro15-4513 (2010) (0)
P-79AN FMRI STUDY OF NALMEFENE ON ALCOHOL EFFECTS IN REWARD ANTICIPATION IN ALCOHOL DEPENDENCE (2015) (0)
Applications of Radiotracer Imaging Poster Abstracts (2012) (0)
Neuroimaging benzodiazepine receptors: effects of disease and drugs (2000) (0)
Specialist treatment of drinking problems (2016) (0)
The GABA benzodiazepine receptor in alcohol use and dependency: a 123I-Iomazenil SPET study (1997) (0)
PET and SPECT studies in alcohol dependence (1999) (0)
Corrigendum to "Prevention of suicide and reduction of self-harm among people with substance use disorder: A systematic review and meta-analysis of randomised controlled trials" [Comprehensive Psychiatry, volume 96 (2020)]. (2022) (0)
Faculty Opinions recommendation of Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting. (2011) (0)
Faculty of 1000 evaluation for Cannabis, COMT and psychotic experiences. (2012) (0)
P.021 Comparison of food cue reactivity, eating behaviours, mood and impulsivity in obesity, ex-smokers and abstinent alcohol dependence (2020) (0)
P.331 The relationship between reward processing and impulsivity in addiction: a functional magnetic resonance imaging study (2020) (0)
Mapping neural activation to alcohol cues in abstinent alcoholics — variability of behavioural and rCBF responses in the scanner environment (2001) (0)
Selective D3 receptor antagonism modulates neural response during negative emotional processing in substance dependence (2022) (0)
Managing setbacks and challenges in treatment (2016) (0)
UvA-DARE (Digital Academic Repository) A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction an international Delphi consensus study (2019) (0)
P.3.017 Human impulsivity is not associated with variation in presynaptic striatal dopamine synthesis capacity (2012) (0)
P.6.c.008 Respiratory changes following benzodiazepine administration in opioid-dependent human participants (2010) (0)
Boosting the diagnostic power of amyloid-β PET using a data-driven spatially informed classifier for decision support (2021) (0)
Alcohol and drug abuse (2000) (0)
Proforma for alcohol health workers (2014) (0)
An exploration of identity change in post-detoxification alcohol dependent individuals (2022) (0)
Introduction to Horizons Review series on neuroimaging. (2017) (0)
A single photon emission tomography (SPET) study of noradrenergic function in generalised anxiety disorder (GAD) (2002) (0)
Reduced GABA benzodiazepine receptor in the absence of atrophy in alcohol dependency: an 123I-Iomazenil SPET and MRI study (1997) (0)
Alcohol dependency and the GABA receptor in males and females: A 123I-Iomazenil SPET study (1997) (0)
P.6.b.005 An fMRI study of nalmefene on alcohol effects in reward anticipation in alcohol dependence (2015) (0)
P.6.d.014 Endogenous opioid blockade modulates neural networks implicated in attentional and behavioural control in individuals recovering from alcohol and drug dependence (2016) (0)
GABA-B receptor function in healthy volunteers, a pharmacokinetic and pharmacodynamic study of two doses of baclofen compared to placebo (2015) (0)
A PET study testing the dopamine hypothesis in opiate dependence in humans (2002) (0)
Case-finding and intervention outside of specialty settings (2016) (0)
Faculty Opinions recommendation of Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. (2011) (0)
Edwards' Treatment of Drinking Problems: A Guide for the Helping Professions (2016) (0)
Dopamine receptor genotypes in non-dependent and dependent smokers (2004) (0)
History of cigarette smoking associated with increased limbic GABA(A) receptor availability (2012) (0)
Regional cerebral increases in opioid receptor density in early abstinence from methadone: a PET study in man (2003) (0)
SPECT, MRI and cognitive studies in alcohol dependence (1998) (0)
Blood flow changes in abstinent addicts during cue exposure and craving for their drug of choice (2002) (0)
SY10-5INVESTIGATING ALCOHOL AND NEUROINFLAMMATION (2015) (0)
In vivo translocator protein positron emission tomography imaging detects a heterogeneity of lesion inflammatory activity in multiple sclerosis not evident by MRI. (2016) (0)
Psychology and Markers (2013) (0)
Functional connectivity analysis of rCBF in opiate craving (2002) (0)
Comparison of food cue reactivity and eating behaviours in obesity, ex-smokers and abstinent alcohol dependence (2020) (0)
S.10.05 Imaging brain opioid receptors in alcohol and heroin dependence (2005) (0)
Authors’ reply (2019) (0)
The therapeutic relationship (2016) (0)
FORWARDS-1: an adaptive, single-blind, placebo-controlled ascending dose study of acute baclofen on safety parameters in opioid dependence during methadone-maintenance treatment—a pharmacokinetic-pharmacodynamic study (2022) (0)
Imaging GABAA receptor subtypes with PET (2002) (0)
A PET study of brain opioid receptor changes after withdrawal from chronic methadone treatment (2002) (0)
Withdrawal states and their clinical management (2016) (0)
P.3.11 Increased opioid receptor binding in early abstinence from dependent opioid and alcohol use and relationship to craving (2007) (0)
Addiction : the clinical interface. Commentary (2008) (0)
Correction to: Service Users’ Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists? (2022) (0)
Acute nutritional state and Body Mass Index influence Anterior Cingulate Cortex activation during motor response inhibition (2018) (0)

This paper list is powered by the following services:

Other Resources About Anne Lingford-Hughes

What Schools Are Affiliated With Anne Lingford-Hughes?

Anne Lingford-Hughes is affiliated with the following schools:

Imperial College London